Elanco Animal Health Incorporated (ELAN)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$22.13
+0.16%
Mkt Cap $11.29B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $1.09B | $1.14B | +4.67% | $0.11 | $0.13 | +18.18% | — | — |
| Q4 2025 Nov 5, 2025 | $1.09B | $1.14B | +4.14% | $0.13 | $0.19 | +46.15% | — | — |
| Q3 2025 Aug 7, 2025 | $1.09B | $1.24B | +13.91% | $0.20 | $0.26 | +30.00% | — | — |
| Q2 2025 May 7, 2025 | $1.18B | $1.19B | +1.28% | $0.31 | $0.37 | +19.35% | — | — |
| Q1 2025 Feb 25, 2025 | $1.21B | $1.02B | -15.70% | $0.16 | $0.14 | -12.50% | — | — |
| Q4 2024 Nov 7, 2024 | $1.01B | $1.03B | +1.68% | $0.12 | $0.13 | +8.33% | — | — |
| Q3 2024 Aug 8, 2024 | $1.15B | $1.18B | +2.84% | $0.24 | $0.30 | +25.00% | — | — |
| Q2 2024 May 8, 2024 | $1.19B | $1.21B | +1.45% | $0.27 | $0.34 | +24.09% | — | — |
| Q1 2024 Feb 26, 2024 | $1.00B | $1.03B | +3.33% | $0.10 | $0.08 | -20.00% | — | — |
| Q4 2023 Nov 7, 2023 | $1.04B | $1.07B | +2.54% | $0.12 | $0.18 | +50.00% | — | — |
| Q3 2023 Aug 7, 2023 | $1.04B | $1.06B | +2.05% | $0.05 | $0.18 | +260.00% | — | — |
| Q2 2023 May 9, 2023 | $1.18B | $1.26B | +6.65% | $0.29 | $0.45 | +55.17% | — | — |
| Q1 2023 Feb 21, 2023 | $980.94M | $988.00M | +0.72% | $0.13 | $0.19 | +46.15% | — | — |
| Q4 2022 Nov 8, 2022 | $1.03B | $1.03B | -0.61% | $0.16 | $0.20 | +25.00% | — | — |
| Q3 2022 Aug 8, 2022 | $1.18B | $1.18B | -0.21% | $0.26 | $0.36 | +38.46% | — | — |
| Q2 2022 May 9, 2022 | $1.22B | $1.23B | +0.66% | $0.35 | $0.36 | +2.86% | — | — |
| Q1 2022 Feb 24, 2022 | $1.10B | $1.11B | +0.84% | $0.17 | $0.21 | +23.53% | — | — |
| Q4 2021 Nov 5, 2021 | $1.11B | $1.13B | +2.25% | $0.17 | $0.19 | +11.76% | — | — |
| Q3 2021 Aug 9, 2021 | $1.28B | $1.28B | +0.00% | $0.26 | $0.28 | +7.69% | — | — |
| Q2 2021 May 7, 2021 | $1.16B | $1.24B | +7.38% | $0.23 | $0.37 | +60.87% | — | — |